Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
PUVA Therapy | 67 | 2018 | 98 | 8.660 |
Why?
|
Psoriasis | 95 | 2023 | 902 | 7.340 |
Why?
|
Carcinoma, Basal Cell | 26 | 2015 | 545 | 3.410 |
Why?
|
Skin Neoplasms | 59 | 2018 | 5692 | 2.460 |
Why?
|
Carcinoma, Squamous Cell | 32 | 2018 | 4034 | 2.090 |
Why?
|
Stevens-Johnson Syndrome | 16 | 2021 | 281 | 1.850 |
Why?
|
Skin Diseases | 21 | 2012 | 1066 | 1.510 |
Why?
|
Drug Eruptions | 13 | 2012 | 297 | 1.220 |
Why?
|
Dermatology | 16 | 2016 | 872 | 1.200 |
Why?
|
Ultraviolet Therapy | 19 | 2010 | 81 | 1.150 |
Why?
|
Ultraviolet Rays | 18 | 2007 | 1060 | 1.140 |
Why?
|
Ficusin | 7 | 2010 | 15 | 0.940 |
Why?
|
Keratinocytes | 3 | 2015 | 799 | 0.910 |
Why?
|
Dermatologic Agents | 10 | 2019 | 278 | 0.860 |
Why?
|
Tretinoin | 5 | 2012 | 517 | 0.750 |
Why?
|
Isotretinoin | 8 | 2010 | 114 | 0.720 |
Why?
|
Methoxsalen | 12 | 2001 | 21 | 0.690 |
Why?
|
Acne Vulgaris | 11 | 2010 | 302 | 0.690 |
Why?
|
Eczema | 2 | 2014 | 231 | 0.650 |
Why?
|
Photosensitizing Agents | 6 | 2007 | 602 | 0.650 |
Why?
|
Office Visits | 8 | 2004 | 598 | 0.640 |
Why?
|
Photochemotherapy | 20 | 1998 | 807 | 0.590 |
Why?
|
Hyaluronic Acid | 4 | 2008 | 491 | 0.590 |
Why?
|
Skin Aging | 5 | 2004 | 127 | 0.580 |
Why?
|
Biological Products | 2 | 2023 | 860 | 0.570 |
Why?
|
Warts | 2 | 2016 | 68 | 0.560 |
Why?
|
Keratolytic Agents | 2 | 2005 | 31 | 0.520 |
Why?
|
Publishing | 6 | 2000 | 833 | 0.480 |
Why?
|
Neoplasms, Radiation-Induced | 8 | 2002 | 547 | 0.470 |
Why?
|
Melanoma | 16 | 2011 | 5511 | 0.440 |
Why?
|
Neoplasms, Basal Cell | 1 | 2012 | 31 | 0.410 |
Why?
|
Epidemiologic Methods | 5 | 2011 | 1364 | 0.410 |
Why?
|
Humans | 242 | 2023 | 744376 | 0.390 |
Why?
|
Skin | 19 | 2017 | 4371 | 0.370 |
Why?
|
Photosensitivity Disorders | 8 | 1995 | 78 | 0.360 |
Why?
|
Patient Satisfaction | 5 | 2007 | 3395 | 0.360 |
Why?
|
Photography | 1 | 2012 | 520 | 0.340 |
Why?
|
Incidence | 25 | 2011 | 20950 | 0.340 |
Why?
|
Anticarcinogenic Agents | 1 | 2011 | 253 | 0.340 |
Why?
|
Male | 136 | 2019 | 350118 | 0.340 |
Why?
|
Epidemiology | 1 | 2011 | 287 | 0.330 |
Why?
|
Health Surveys | 5 | 2016 | 4036 | 0.330 |
Why?
|
Health Services Research | 1 | 2016 | 1836 | 0.330 |
Why?
|
Sunlight | 10 | 2005 | 325 | 0.330 |
Why?
|
Middle Aged | 111 | 2019 | 213388 | 0.320 |
Why?
|
Female | 141 | 2019 | 380200 | 0.320 |
Why?
|
Genital Neoplasms, Male | 3 | 2002 | 74 | 0.320 |
Why?
|
Periodicals as Topic | 4 | 2000 | 1431 | 0.320 |
Why?
|
Exanthema | 1 | 2012 | 501 | 0.300 |
Why?
|
Physicians' Offices | 2 | 2005 | 58 | 0.300 |
Why?
|
Acute Disease | 2 | 2018 | 7147 | 0.300 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2013 | 9240 | 0.300 |
Why?
|
Suicidal Ideation | 2 | 2014 | 1246 | 0.300 |
Why?
|
Adult | 113 | 2021 | 214056 | 0.290 |
Why?
|
Quality of Life | 12 | 2010 | 12803 | 0.290 |
Why?
|
Patient Care | 1 | 2012 | 640 | 0.290 |
Why?
|
Cataract | 3 | 2007 | 834 | 0.280 |
Why?
|
Carbohydrates | 1 | 2008 | 394 | 0.280 |
Why?
|
Drug Prescriptions | 4 | 2005 | 1637 | 0.280 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1831 | 0.280 |
Why?
|
Teratogens | 2 | 2005 | 112 | 0.270 |
Why?
|
Sunscreening Agents | 5 | 2004 | 132 | 0.270 |
Why?
|
Conflict of Interest | 1 | 2010 | 544 | 0.260 |
Why?
|
Health Maintenance Organizations | 5 | 1998 | 642 | 0.260 |
Why?
|
Ambulatory Care | 6 | 2005 | 2708 | 0.250 |
Why?
|
Sickness Impact Profile | 1 | 2006 | 302 | 0.250 |
Why?
|
Nicotinic Acids | 1 | 2004 | 31 | 0.250 |
Why?
|
Cyclosporine | 3 | 2017 | 788 | 0.250 |
Why?
|
Foundations | 1 | 2005 | 94 | 0.250 |
Why?
|
Lentigo | 5 | 2004 | 37 | 0.250 |
Why?
|
Severity of Illness Index | 19 | 2017 | 15535 | 0.240 |
Why?
|
Polymers | 2 | 2008 | 1621 | 0.240 |
Why?
|
United States | 40 | 2018 | 69869 | 0.230 |
Why?
|
Retinoids | 1 | 2003 | 101 | 0.220 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2011 | 2282 | 0.220 |
Why?
|
Aged | 60 | 2019 | 163284 | 0.220 |
Why?
|
Cause of Death | 2 | 2011 | 3582 | 0.220 |
Why?
|
Abnormalities, Drug-Induced | 4 | 1992 | 317 | 0.220 |
Why?
|
Pigmentation Disorders | 2 | 2003 | 101 | 0.220 |
Why?
|
Psychometrics | 4 | 2007 | 3002 | 0.220 |
Why?
|
Tacrolimus | 1 | 2006 | 743 | 0.220 |
Why?
|
Risk | 20 | 2011 | 9688 | 0.210 |
Why?
|
Etretinate | 2 | 1995 | 6 | 0.210 |
Why?
|
Biological Factors | 1 | 2023 | 164 | 0.210 |
Why?
|
Carbamazepine | 2 | 2007 | 229 | 0.210 |
Why?
|
Patient Advocacy | 1 | 2005 | 353 | 0.210 |
Why?
|
Cohort Studies | 20 | 2023 | 40558 | 0.210 |
Why?
|
Genitalia, Male | 1 | 2002 | 84 | 0.210 |
Why?
|
Biological Therapy | 1 | 2023 | 138 | 0.210 |
Why?
|
Prospective Studies | 31 | 2016 | 53291 | 0.210 |
Why?
|
Penile Neoplasms | 2 | 2002 | 161 | 0.210 |
Why?
|
Cosmetic Techniques | 1 | 2004 | 135 | 0.210 |
Why?
|
Clobetasol | 1 | 2002 | 34 | 0.210 |
Why?
|
Follow-Up Studies | 29 | 2018 | 39052 | 0.210 |
Why?
|
Coal Tar | 6 | 1988 | 17 | 0.210 |
Why?
|
Adjuvants, Immunologic | 2 | 2008 | 1000 | 0.200 |
Why?
|
Professional Practice | 1 | 2004 | 326 | 0.200 |
Why?
|
Pemphigoid, Bullous | 2 | 2002 | 109 | 0.200 |
Why?
|
Adrenal Cortex Hormones | 4 | 1996 | 1856 | 0.200 |
Why?
|
Immunosuppressive Agents | 2 | 2006 | 4153 | 0.190 |
Why?
|
Cost of Illness | 4 | 2006 | 1860 | 0.190 |
Why?
|
Health Status Indicators | 1 | 2006 | 970 | 0.180 |
Why?
|
Risk Factors | 29 | 2018 | 72295 | 0.180 |
Why?
|
Dermatitis, Atopic | 2 | 2006 | 654 | 0.180 |
Why?
|
Genes, p53 | 1 | 2002 | 755 | 0.180 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1939 | 0.180 |
Why?
|
Dose-Response Relationship, Radiation | 10 | 1999 | 876 | 0.170 |
Why?
|
Phenytoin | 2 | 1997 | 197 | 0.170 |
Why?
|
Family Practice | 3 | 2000 | 516 | 0.170 |
Why?
|
Phototherapy | 2 | 2018 | 377 | 0.160 |
Why?
|
Lymphoma | 2 | 2006 | 1877 | 0.160 |
Why?
|
Preferred Provider Organizations | 1 | 1998 | 38 | 0.160 |
Why?
|
Time Factors | 28 | 2012 | 40077 | 0.160 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2002 | 397 | 0.160 |
Why?
|
Keratosis, Actinic | 1 | 2019 | 74 | 0.160 |
Why?
|
Radiation Dosage | 4 | 2005 | 1928 | 0.160 |
Why?
|
Drug Utilization | 3 | 2000 | 1183 | 0.160 |
Why?
|
Immunologic Factors | 1 | 2007 | 1580 | 0.150 |
Why?
|
Clomipramine | 5 | 1980 | 54 | 0.150 |
Why?
|
HIV Seronegativity | 1 | 1998 | 211 | 0.150 |
Why?
|
Laser Therapy | 7 | 2004 | 1072 | 0.150 |
Why?
|
Neoplasms, Second Primary | 2 | 2002 | 1062 | 0.150 |
Why?
|
Prednisone | 1 | 2002 | 1574 | 0.150 |
Why?
|
Medical Records | 4 | 2008 | 1413 | 0.150 |
Why?
|
Mycosis Fungoides | 1 | 2018 | 163 | 0.140 |
Why?
|
Adolescent | 44 | 2014 | 85784 | 0.140 |
Why?
|
Interleukin-15 | 1 | 2017 | 184 | 0.140 |
Why?
|
Confidence Intervals | 4 | 2004 | 2971 | 0.140 |
Why?
|
Cardiovascular Diseases | 3 | 2011 | 15159 | 0.140 |
Why?
|
Skin Diseases, Bacterial | 1 | 2016 | 66 | 0.140 |
Why?
|
Authorship | 1 | 1999 | 271 | 0.130 |
Why?
|
Insurance, Health | 2 | 2023 | 2494 | 0.130 |
Why?
|
Laser Coagulation | 2 | 1995 | 326 | 0.130 |
Why?
|
Ambulatory Care Facilities | 1 | 2002 | 934 | 0.130 |
Why?
|
Costs and Cost Analysis | 8 | 1989 | 1680 | 0.130 |
Why?
|
Models, Statistical | 1 | 2010 | 5101 | 0.130 |
Why?
|
HIV Seropositivity | 2 | 1998 | 971 | 0.130 |
Why?
|
Health Care Surveys | 4 | 2005 | 2453 | 0.120 |
Why?
|
Methotrexate | 5 | 2017 | 1728 | 0.120 |
Why?
|
Multivariate Analysis | 6 | 2014 | 12244 | 0.120 |
Why?
|
Valproic Acid | 1 | 1997 | 445 | 0.120 |
Why?
|
Carcinoma, Merkel Cell | 1 | 1998 | 303 | 0.120 |
Why?
|
Behavior Therapy | 5 | 1983 | 865 | 0.120 |
Why?
|
Chronic Disease | 6 | 2018 | 9145 | 0.120 |
Why?
|
United States Food and Drug Administration | 4 | 2006 | 1584 | 0.120 |
Why?
|
Calcitriol | 1 | 1995 | 297 | 0.120 |
Why?
|
Cocarcinogenesis | 2 | 1992 | 54 | 0.120 |
Why?
|
Probability | 5 | 2003 | 2506 | 0.120 |
Why?
|
Mental Disorders | 1 | 2014 | 6600 | 0.120 |
Why?
|
Skin Diseases, Infectious | 1 | 1994 | 74 | 0.120 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 1994 | 657 | 0.110 |
Why?
|
Risk Assessment | 10 | 2019 | 23336 | 0.110 |
Why?
|
Age Factors | 14 | 2018 | 18373 | 0.110 |
Why?
|
Administration, Topical | 6 | 2002 | 690 | 0.110 |
Why?
|
Pharmacology, Clinical | 1 | 1993 | 21 | 0.110 |
Why?
|
Dapsone | 1 | 1993 | 54 | 0.110 |
Why?
|
Tars | 4 | 1994 | 20 | 0.110 |
Why?
|
Prevalence | 7 | 2014 | 15221 | 0.110 |
Why?
|
Obsessive-Compulsive Disorder | 7 | 1980 | 1444 | 0.110 |
Why?
|
Odds Ratio | 6 | 2007 | 9849 | 0.110 |
Why?
|
Drug Evaluation | 2 | 1991 | 647 | 0.110 |
Why?
|
Aging | 3 | 2008 | 8663 | 0.110 |
Why?
|
Affective Symptoms | 2 | 2014 | 407 | 0.110 |
Why?
|
Case-Control Studies | 8 | 2011 | 21747 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2002 | 2108 | 0.110 |
Why?
|
Acitretin | 2 | 2017 | 14 | 0.100 |
Why?
|
Radiotherapy | 2 | 2018 | 1533 | 0.100 |
Why?
|
Anticonvulsants | 3 | 1999 | 1916 | 0.100 |
Why?
|
Telangiectasis | 2 | 2004 | 76 | 0.100 |
Why?
|
Transplantation Conditioning | 1 | 2018 | 1599 | 0.100 |
Why?
|
Cost-Benefit Analysis | 3 | 2018 | 5390 | 0.100 |
Why?
|
Drug Industry | 2 | 2004 | 746 | 0.100 |
Why?
|
Dermatitis, Seborrheic | 1 | 1991 | 7 | 0.100 |
Why?
|
Diagnosis-Related Groups | 4 | 1990 | 455 | 0.100 |
Why?
|
Cryotherapy | 2 | 2019 | 155 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 2 | 1997 | 895 | 0.100 |
Why?
|
Data Collection | 2 | 1999 | 3339 | 0.100 |
Why?
|
Bullying | 1 | 2014 | 210 | 0.100 |
Why?
|
Hospitalization | 6 | 2005 | 10259 | 0.100 |
Why?
|
Age Distribution | 3 | 2002 | 2902 | 0.100 |
Why?
|
Hand | 1 | 2016 | 884 | 0.100 |
Why?
|
Medical Record Linkage | 3 | 1987 | 284 | 0.100 |
Why?
|
Keratosis | 1 | 1991 | 81 | 0.090 |
Why?
|
Managed Care Programs | 1 | 1996 | 950 | 0.090 |
Why?
|
Nevus, Pigmented | 1 | 1993 | 219 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2007 | 9274 | 0.090 |
Why?
|
Skin Pigmentation | 5 | 1995 | 282 | 0.090 |
Why?
|
Social Behavior Disorders | 1 | 2010 | 97 | 0.090 |
Why?
|
Fluoroquinolones | 2 | 2007 | 310 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2000 | 1140 | 0.090 |
Why?
|
Consensus Development Conferences as Topic | 1 | 1991 | 170 | 0.090 |
Why?
|
Administration, Cutaneous | 2 | 2006 | 711 | 0.090 |
Why?
|
Anti-Bacterial Agents | 4 | 2000 | 7182 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2005 | 3922 | 0.090 |
Why?
|
Administration, Oral | 5 | 2002 | 3914 | 0.090 |
Why?
|
Prognosis | 7 | 2018 | 29060 | 0.090 |
Why?
|
Practice Guidelines as Topic | 5 | 2019 | 7281 | 0.090 |
Why?
|
Medicare | 3 | 2002 | 6566 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2002 | 10943 | 0.090 |
Why?
|
Treatment Outcome | 13 | 2018 | 63115 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1998 | 2232 | 0.090 |
Why?
|
Cryosurgery | 1 | 1994 | 453 | 0.090 |
Why?
|
Cyclosporins | 1 | 1989 | 220 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2019 | 57776 | 0.080 |
Why?
|
Primary Health Care | 4 | 2019 | 4557 | 0.080 |
Why?
|
Erythema | 5 | 1999 | 257 | 0.080 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2008 | 133 | 0.080 |
Why?
|
Abortion, Induced | 2 | 1992 | 458 | 0.080 |
Why?
|
Child | 24 | 2021 | 77708 | 0.080 |
Why?
|
Australia | 2 | 2009 | 1167 | 0.080 |
Why?
|
Erythema Multiforme | 3 | 1993 | 31 | 0.080 |
Why?
|
Drug Labeling | 2 | 2006 | 233 | 0.080 |
Why?
|
Biopolymers | 1 | 2008 | 189 | 0.080 |
Why?
|
Melanocytes | 3 | 1988 | 515 | 0.080 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 1988 | 63 | 0.080 |
Why?
|
Registries | 5 | 2017 | 8091 | 0.080 |
Why?
|
Inflammation | 1 | 2007 | 10636 | 0.080 |
Why?
|
Workflow | 1 | 2012 | 847 | 0.080 |
Why?
|
Sweden | 3 | 2000 | 1346 | 0.080 |
Why?
|
New Hampshire | 1 | 2007 | 172 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1596 | 0.070 |
Why?
|
Skin Physiological Phenomena | 1 | 2008 | 180 | 0.070 |
Why?
|
Thermodynamics | 1 | 2008 | 594 | 0.070 |
Why?
|
Social Behavior | 1 | 2014 | 1127 | 0.070 |
Why?
|
Clinical Trials as Topic | 13 | 2009 | 7914 | 0.070 |
Why?
|
Thiazines | 2 | 1984 | 38 | 0.070 |
Why?
|
Minoxidil | 1 | 1987 | 33 | 0.070 |
Why?
|
Massachusetts | 7 | 2006 | 8662 | 0.070 |
Why?
|
Disaccharides | 1 | 2007 | 171 | 0.070 |
Why?
|
Sex Factors | 9 | 2004 | 10400 | 0.070 |
Why?
|
HLA-B Antigens | 1 | 2007 | 354 | 0.070 |
Why?
|
Sulfadoxine | 1 | 2006 | 49 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2004 | 5321 | 0.070 |
Why?
|
Physical Examination | 1 | 1992 | 1237 | 0.070 |
Why?
|
Skin Diseases, Vesiculobullous | 2 | 2002 | 85 | 0.070 |
Why?
|
Pyrimethamine | 1 | 2006 | 97 | 0.070 |
Why?
|
Ambulatory Surgical Procedures | 1 | 1991 | 454 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 3 | 1985 | 1790 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 2958 | 0.070 |
Why?
|
HLA-DR Antigens | 1 | 2007 | 645 | 0.070 |
Why?
|
Online Systems | 1 | 1986 | 184 | 0.070 |
Why?
|
Pregnancy | 9 | 2006 | 29144 | 0.070 |
Why?
|
Sulfonamides | 3 | 1995 | 1940 | 0.070 |
Why?
|
Hospitals, University | 2 | 2006 | 570 | 0.070 |
Why?
|
Drug Hypersensitivity | 3 | 1997 | 884 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3020 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2021 | 77459 | 0.060 |
Why?
|
Sex Distribution | 2 | 2000 | 2297 | 0.060 |
Why?
|
Triiodothyronine | 1 | 2007 | 494 | 0.060 |
Why?
|
Databases, Factual | 2 | 2019 | 7730 | 0.060 |
Why?
|
Activities of Daily Living | 4 | 2007 | 2418 | 0.060 |
Why?
|
Psychotherapy, Rational-Emotive | 2 | 1982 | 2 | 0.060 |
Why?
|
Combined Modality Therapy | 6 | 2017 | 8642 | 0.060 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 1986 | 204 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4424 | 0.060 |
Why?
|
Culture Media | 1 | 2007 | 909 | 0.060 |
Why?
|
Financial Management, Hospital | 1 | 1985 | 74 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2007 | 595 | 0.060 |
Why?
|
Therapy, Computer-Assisted | 1 | 1986 | 274 | 0.060 |
Why?
|
Molecular Structure | 1 | 2008 | 1899 | 0.060 |
Why?
|
Prospective Payment System | 1 | 1985 | 133 | 0.060 |
Why?
|
HIV Infections | 4 | 1998 | 16715 | 0.060 |
Why?
|
Pregnancy Complications | 4 | 1995 | 2861 | 0.060 |
Why?
|
Office Management | 1 | 1983 | 14 | 0.060 |
Why?
|
Patient Admission | 1 | 1991 | 1380 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 1997 | 2282 | 0.060 |
Why?
|
Netherlands | 2 | 2019 | 2170 | 0.060 |
Why?
|
Ibuprofen | 1 | 1985 | 236 | 0.060 |
Why?
|
Lens, Crystalline | 1 | 1985 | 388 | 0.060 |
Why?
|
Financial Management | 1 | 1985 | 160 | 0.060 |
Why?
|
Regression Analysis | 3 | 2006 | 6459 | 0.060 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2005 | 392 | 0.060 |
Why?
|
Imipramine | 1 | 1983 | 97 | 0.060 |
Why?
|
Dermatitis | 1 | 1985 | 199 | 0.060 |
Why?
|
Alopecia | 1 | 1987 | 382 | 0.050 |
Why?
|
Forms and Records Control | 1 | 1983 | 160 | 0.050 |
Why?
|
Agoraphobia | 1 | 1983 | 179 | 0.050 |
Why?
|
Arthritis, Psoriatic | 1 | 2005 | 215 | 0.050 |
Why?
|
Poverty | 2 | 1991 | 2660 | 0.050 |
Why?
|
International Cooperation | 3 | 2003 | 1420 | 0.050 |
Why?
|
Liver Diseases | 1 | 2011 | 1253 | 0.050 |
Why?
|
Confidentiality | 1 | 1986 | 612 | 0.050 |
Why?
|
Botulinum Toxins | 1 | 2004 | 191 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2007 | 1677 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7323 | 0.050 |
Why?
|
Models, Biological | 3 | 2008 | 9584 | 0.050 |
Why?
|
Polysaccharides | 1 | 2008 | 1059 | 0.050 |
Why?
|
Attitude to Health | 3 | 2001 | 2052 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 1992 | 2795 | 0.050 |
Why?
|
Bowen's Disease | 1 | 2000 | 12 | 0.050 |
Why?
|
Chemoprevention | 1 | 2003 | 319 | 0.050 |
Why?
|
Italy | 2 | 2017 | 832 | 0.050 |
Why?
|
Haplotypes | 1 | 2007 | 2779 | 0.050 |
Why?
|
Length of Stay | 4 | 1990 | 6311 | 0.050 |
Why?
|
France | 1 | 2002 | 517 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2014 | 25041 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5445 | 0.050 |
Why?
|
Environmental Exposure | 2 | 2005 | 4232 | 0.050 |
Why?
|
Phobic Disorders | 1 | 1983 | 439 | 0.050 |
Why?
|
Wound Healing | 3 | 2008 | 2785 | 0.050 |
Why?
|
Lighting | 1 | 1982 | 231 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 1991 | 2212 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2008 | 1741 | 0.050 |
Why?
|
Drug Approval | 1 | 2006 | 742 | 0.040 |
Why?
|
Leg Dermatoses | 1 | 1999 | 20 | 0.040 |
Why?
|
Argon | 3 | 1995 | 36 | 0.040 |
Why?
|
Product Surveillance, Postmarketing | 3 | 2008 | 430 | 0.040 |
Why?
|
Arthritis | 1 | 1985 | 659 | 0.040 |
Why?
|
Renal Insufficiency | 1 | 2005 | 804 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2005 | 7658 | 0.040 |
Why?
|
Abortion, Spontaneous | 3 | 1992 | 544 | 0.040 |
Why?
|
Logistic Models | 3 | 2005 | 13409 | 0.040 |
Why?
|
Antimalarials | 1 | 2006 | 905 | 0.040 |
Why?
|
Internship and Residency | 4 | 2002 | 5789 | 0.040 |
Why?
|
Mutation | 2 | 2002 | 29786 | 0.040 |
Why?
|
Reimbursement Mechanisms | 1 | 1985 | 670 | 0.040 |
Why?
|
Pruritus | 2 | 1998 | 361 | 0.040 |
Why?
|
Emollients | 3 | 1988 | 34 | 0.040 |
Why?
|
Insurance, Physician Services | 1 | 1998 | 24 | 0.040 |
Why?
|
Aspirin | 1 | 2011 | 3283 | 0.040 |
Why?
|
Depression | 5 | 2014 | 7766 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2005 | 1405 | 0.040 |
Why?
|
Neoplasms | 4 | 1995 | 21693 | 0.040 |
Why?
|
Grief | 1 | 1981 | 248 | 0.040 |
Why?
|
Research Design | 3 | 2007 | 5986 | 0.040 |
Why?
|
Folliculitis | 1 | 1998 | 28 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 3773 | 0.040 |
Why?
|
Rural Health | 1 | 1980 | 305 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 1979 | 326 | 0.040 |
Why?
|
Europe | 2 | 2008 | 3339 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2007 | 13988 | 0.040 |
Why?
|
Attitude to Death | 1 | 1981 | 382 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2001 | 2029 | 0.040 |
Why?
|
Czech Republic | 1 | 2017 | 69 | 0.040 |
Why?
|
Anti-Infective Agents | 2 | 1996 | 974 | 0.040 |
Why?
|
Databases as Topic | 1 | 2000 | 475 | 0.040 |
Why?
|
General Practitioners | 1 | 2019 | 103 | 0.040 |
Why?
|
Medical Staff, Hospital | 1 | 2002 | 601 | 0.040 |
Why?
|
Internal Medicine | 2 | 1986 | 1009 | 0.040 |
Why?
|
Smoking | 2 | 2011 | 8987 | 0.040 |
Why?
|
Austria | 1 | 2017 | 203 | 0.040 |
Why?
|
Dibenzazepines | 1 | 1977 | 26 | 0.040 |
Why?
|
Antifungal Agents | 1 | 1982 | 729 | 0.040 |
Why?
|
Triazines | 1 | 1999 | 315 | 0.040 |
Why?
|
Psychotherapy | 3 | 2007 | 1643 | 0.040 |
Why?
|
Body Surface Area | 2 | 1996 | 199 | 0.040 |
Why?
|
Prepaid Health Plans | 1 | 1996 | 10 | 0.040 |
Why?
|
Cell Membrane | 1 | 2007 | 3749 | 0.040 |
Why?
|
Fumarates | 1 | 2017 | 132 | 0.040 |
Why?
|
Drug Combinations | 2 | 2006 | 1958 | 0.040 |
Why?
|
Private Practice | 1 | 1977 | 154 | 0.040 |
Why?
|
Tattooing | 1 | 1997 | 58 | 0.040 |
Why?
|
Child, Preschool | 9 | 2006 | 41005 | 0.040 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 6489 | 0.030 |
Why?
|
Fibroblasts | 1 | 2007 | 4162 | 0.030 |
Why?
|
Mental Health | 1 | 2010 | 3014 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15295 | 0.030 |
Why?
|
Malaria | 1 | 2006 | 1239 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3255 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 1986 | 2104 | 0.030 |
Why?
|
Imidazoles | 1 | 1982 | 1206 | 0.030 |
Why?
|
Random Allocation | 4 | 1989 | 2428 | 0.030 |
Why?
|
Inpatients | 2 | 2003 | 2518 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2000 | 652 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2007 | 4561 | 0.030 |
Why?
|
Carbon Dioxide | 4 | 1994 | 1150 | 0.030 |
Why?
|
Serum Sickness | 1 | 1994 | 28 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 1997 | 12961 | 0.030 |
Why?
|
Israel | 1 | 2017 | 796 | 0.030 |
Why?
|
Lasers | 3 | 1997 | 952 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2838 | 0.030 |
Why?
|
DNA | 1 | 1989 | 7294 | 0.030 |
Why?
|
Piroxicam | 2 | 1984 | 18 | 0.030 |
Why?
|
Urinary Incontinence | 2 | 1991 | 496 | 0.030 |
Why?
|
Double-Blind Method | 7 | 2007 | 12025 | 0.030 |
Why?
|
Surgery, Plastic | 3 | 1993 | 624 | 0.030 |
Why?
|
Occupational Diseases | 1 | 1982 | 1469 | 0.030 |
Why?
|
Granuloma | 1 | 2016 | 319 | 0.030 |
Why?
|
Eosinophilia | 1 | 1998 | 541 | 0.030 |
Why?
|
Physicians | 2 | 1996 | 4567 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 9957 | 0.030 |
Why?
|
Hospitals, Teaching | 2 | 1991 | 1180 | 0.030 |
Why?
|
Safety | 1 | 1998 | 1186 | 0.030 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 1973 | 75 | 0.030 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 1993 | 94 | 0.030 |
Why?
|
Angioedema | 1 | 1994 | 187 | 0.030 |
Why?
|
Nitrogen | 1 | 1994 | 344 | 0.030 |
Why?
|
Hamartoma | 1 | 1995 | 238 | 0.030 |
Why?
|
Aftercare | 1 | 2019 | 870 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2006 | 25628 | 0.030 |
Why?
|
Allopurinol | 2 | 1995 | 191 | 0.030 |
Why?
|
Epidermolysis Bullosa Dystrophica | 1 | 1992 | 26 | 0.030 |
Why?
|
Health Care Rationing | 1 | 1996 | 437 | 0.030 |
Why?
|
Family Therapy | 1 | 1973 | 207 | 0.030 |
Why?
|
Research | 1 | 2021 | 1999 | 0.030 |
Why?
|
Health Status | 1 | 2005 | 4033 | 0.030 |
Why?
|
Respiratory Tract Neoplasms | 1 | 1992 | 57 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 1998 | 2560 | 0.030 |
Why?
|
Insurance, Hospitalization | 1 | 1991 | 30 | 0.030 |
Why?
|
Marriage | 1 | 1973 | 339 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2960 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 1998 | 3508 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 1997 | 20823 | 0.030 |
Why?
|
Information Services | 1 | 1993 | 244 | 0.030 |
Why?
|
Piperazines | 1 | 1982 | 2488 | 0.020 |
Why?
|
Drugs, Generic | 1 | 1996 | 421 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2006 | 469 | 0.020 |
Why?
|
Quinolones | 1 | 1994 | 367 | 0.020 |
Why?
|
Life Tables | 1 | 1991 | 370 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2007 | 19233 | 0.020 |
Why?
|
Joint Diseases | 1 | 1995 | 479 | 0.020 |
Why?
|
Referral and Consultation | 2 | 2019 | 3529 | 0.020 |
Why?
|
Infant | 5 | 2006 | 35134 | 0.020 |
Why?
|
beta Carotene | 1 | 1992 | 527 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 1983 | 2400 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 1982 | 2690 | 0.020 |
Why?
|
Thinking | 1 | 1973 | 318 | 0.020 |
Why?
|
Vasculitis | 1 | 1994 | 519 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.020 |
Why?
|
Contraception Behavior | 1 | 1992 | 185 | 0.020 |
Why?
|
Young Adult | 2 | 2014 | 56434 | 0.020 |
Why?
|
Genes, Dominant | 1 | 1973 | 880 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4777 | 0.020 |
Why?
|
MEDLARS | 1 | 1989 | 5 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 15078 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2002 | 2133 | 0.020 |
Why?
|
Scrotum | 1 | 1990 | 115 | 0.020 |
Why?
|
Eye Diseases | 1 | 1995 | 669 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1998 | 6366 | 0.020 |
Why?
|
Quality of Health Care | 1 | 1985 | 4369 | 0.020 |
Why?
|
Beta Particles | 1 | 1989 | 50 | 0.020 |
Why?
|
Twins | 1 | 1991 | 339 | 0.020 |
Why?
|
Movement Disorders | 1 | 1973 | 446 | 0.020 |
Why?
|
Pilot Projects | 3 | 2007 | 8319 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2007 | 4644 | 0.020 |
Why?
|
Survival Analysis | 1 | 2002 | 10252 | 0.020 |
Why?
|
Urodynamics | 1 | 1991 | 347 | 0.020 |
Why?
|
Hospitals, Community | 1 | 1991 | 347 | 0.020 |
Why?
|
Carotenoids | 1 | 1992 | 624 | 0.020 |
Why?
|
Fetal Death | 1 | 1991 | 448 | 0.020 |
Why?
|
Nevus | 1 | 1991 | 204 | 0.020 |
Why?
|
Psychology | 1 | 2010 | 356 | 0.020 |
Why?
|
Mice | 5 | 2007 | 81202 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2265 | 0.020 |
Why?
|
Muscular Diseases | 1 | 1973 | 555 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 1986 | 1782 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2007 | 6038 | 0.020 |
Why?
|
Hospitals | 2 | 1994 | 3954 | 0.020 |
Why?
|
Drug Interactions | 1 | 1993 | 1460 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1956 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1992 | 547 | 0.020 |
Why?
|
Socioeconomic Factors | 4 | 1994 | 7785 | 0.020 |
Why?
|
Panniculitis, Nodular Nonsuppurative | 1 | 1987 | 7 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 1985 | 5135 | 0.020 |
Why?
|
Hemoptysis | 1 | 1989 | 155 | 0.020 |
Why?
|
Compulsive Behavior | 2 | 1981 | 117 | 0.020 |
Why?
|
Emigration and Immigration | 1 | 1990 | 402 | 0.020 |
Why?
|
Familial Mediterranean Fever | 1 | 1987 | 61 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6539 | 0.020 |
Why?
|
Drug Monitoring | 1 | 1993 | 956 | 0.020 |
Why?
|
Actuarial Analysis | 1 | 1986 | 378 | 0.020 |
Why?
|
Pharmaceutical Vehicles | 1 | 1986 | 59 | 0.020 |
Why?
|
Myxedema | 1 | 2005 | 17 | 0.020 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2006 | 54 | 0.020 |
Why?
|
Lens Diseases | 1 | 1985 | 13 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 17445 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 1992 | 806 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1988 | 963 | 0.020 |
Why?
|
Observer Variation | 1 | 1992 | 2593 | 0.020 |
Why?
|
Medically Uninsured | 1 | 1991 | 853 | 0.020 |
Why?
|
Musculoskeletal System | 1 | 1988 | 175 | 0.020 |
Why?
|
Solutions | 1 | 1986 | 426 | 0.020 |
Why?
|
Capital Expenditures | 1 | 1985 | 29 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1993 | 1257 | 0.020 |
Why?
|
Patient Compliance | 3 | 1986 | 2685 | 0.020 |
Why?
|
Animals | 6 | 2007 | 168770 | 0.020 |
Why?
|
Meclofenamic Acid | 1 | 1984 | 24 | 0.020 |
Why?
|
Boston | 4 | 1989 | 9312 | 0.020 |
Why?
|
Malawi | 1 | 2006 | 282 | 0.020 |
Why?
|
Psychophysiologic Disorders | 1 | 1987 | 228 | 0.020 |
Why?
|
Tolmetin | 1 | 1984 | 23 | 0.020 |
Why?
|
Medicaid | 1 | 1998 | 2737 | 0.020 |
Why?
|
Urinary Incontinence, Stress | 1 | 1987 | 183 | 0.020 |
Why?
|
Sulindac | 1 | 1984 | 29 | 0.020 |
Why?
|
Vaginitis | 1 | 1984 | 47 | 0.020 |
Why?
|
Arousal | 1 | 1991 | 1164 | 0.020 |
Why?
|
Hospitals, Special | 1 | 1985 | 101 | 0.020 |
Why?
|
Relaxation Therapy | 2 | 1983 | 178 | 0.020 |
Why?
|
Choroid Neoplasms | 1 | 1985 | 175 | 0.020 |
Why?
|
Propionates | 1 | 1984 | 169 | 0.010 |
Why?
|
Pityriasis | 1 | 1983 | 10 | 0.010 |
Why?
|
Eye | 1 | 1988 | 729 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11031 | 0.010 |
Why?
|
Demography | 2 | 1994 | 1656 | 0.010 |
Why?
|
Epilepsy | 1 | 1999 | 3310 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 1994 | 4851 | 0.010 |
Why?
|
Diagnostic Services | 1 | 1983 | 34 | 0.010 |
Why?
|
Patient Dropouts | 1 | 1986 | 421 | 0.010 |
Why?
|
Desensitization, Psychologic | 1 | 1983 | 28 | 0.010 |
Why?
|
Leisure Activities | 1 | 1985 | 311 | 0.010 |
Why?
|
Autosuggestion | 1 | 1982 | 1 | 0.010 |
Why?
|
Health Resources | 1 | 1989 | 911 | 0.010 |
Why?
|
Drug Synergism | 1 | 2007 | 1797 | 0.010 |
Why?
|
Skin Tests | 1 | 1984 | 613 | 0.010 |
Why?
|
Ketoconazole | 1 | 1982 | 95 | 0.010 |
Why?
|
Efficiency | 1 | 1985 | 462 | 0.010 |
Why?
|
Social Adjustment | 2 | 1981 | 631 | 0.010 |
Why?
|
General Surgery | 1 | 1993 | 1636 | 0.010 |
Why?
|
Chlorothiazide | 1 | 1980 | 7 | 0.010 |
Why?
|
Demeclocycline | 1 | 1980 | 5 | 0.010 |
Why?
|
Germany | 1 | 2003 | 862 | 0.010 |
Why?
|
Nalidixic Acid | 1 | 1980 | 19 | 0.010 |
Why?
|
Social Class | 1 | 1990 | 1997 | 0.010 |
Why?
|
Hypertrophy | 2 | 1997 | 569 | 0.010 |
Why?
|
Remission Induction | 1 | 1986 | 2386 | 0.010 |
Why?
|
Sunburn | 1 | 1982 | 155 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 1996 | 19905 | 0.010 |
Why?
|
Immunity | 1 | 1987 | 1014 | 0.010 |
Why?
|
Central Nervous System | 1 | 1988 | 1357 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1984 | 2327 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1986 | 1375 | 0.010 |
Why?
|
Tetracycline | 1 | 1980 | 214 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 1993 | 14723 | 0.010 |
Why?
|
Furosemide | 1 | 1980 | 167 | 0.010 |
Why?
|
Pregnancy Trimester, First | 1 | 1984 | 853 | 0.010 |
Why?
|
Microcephaly | 1 | 1984 | 432 | 0.010 |
Why?
|
Patient Readmission | 1 | 1994 | 3116 | 0.010 |
Why?
|
Sulfonylurea Compounds | 1 | 1980 | 205 | 0.010 |
Why?
|
Population Surveillance | 1 | 1990 | 2616 | 0.010 |
Why?
|
Missouri | 1 | 1978 | 117 | 0.010 |
Why?
|
Medical History Taking | 1 | 1982 | 784 | 0.010 |
Why?
|
Lung Diseases | 1 | 1989 | 1887 | 0.010 |
Why?
|
Placebos | 1 | 1983 | 1676 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 1988 | 1862 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 1979 | 258 | 0.010 |
Why?
|
Preceptorship | 1 | 1978 | 61 | 0.010 |
Why?
|
Fees and Charges | 2 | 1990 | 195 | 0.010 |
Why?
|
Physicians, Family | 1 | 1980 | 345 | 0.010 |
Why?
|
Hydrocephalus | 1 | 1984 | 748 | 0.010 |
Why?
|
Disability Evaluation | 1 | 1985 | 1827 | 0.010 |
Why?
|
Fetal Diseases | 1 | 1983 | 903 | 0.010 |
Why?
|
Neodymium | 1 | 1997 | 21 | 0.010 |
Why?
|
Self Care | 1 | 1983 | 786 | 0.010 |
Why?
|
Aluminum Silicates | 1 | 1997 | 26 | 0.010 |
Why?
|
Aluminum Oxide | 1 | 1997 | 42 | 0.010 |
Why?
|
Anaphylaxis | 1 | 1984 | 746 | 0.010 |
Why?
|
Yttrium | 1 | 1997 | 35 | 0.010 |
Why?
|
Stress, Psychological | 2 | 1991 | 4244 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 1983 | 783 | 0.010 |
Why?
|
Fees, Medical | 1 | 1977 | 117 | 0.010 |
Why?
|
New England | 1 | 1980 | 1022 | 0.010 |
Why?
|
Hypopigmentation | 1 | 1997 | 41 | 0.010 |
Why?
|
Occupations | 2 | 1990 | 517 | 0.010 |
Why?
|
Hemorrhage | 1 | 1989 | 3461 | 0.010 |
Why?
|
Visual Acuity | 1 | 1985 | 2530 | 0.010 |
Why?
|
Chlormezanone | 1 | 1995 | 1 | 0.010 |
Why?
|
Environment | 1 | 1982 | 1123 | 0.010 |
Why?
|
Cicatrix | 2 | 1995 | 764 | 0.010 |
Why?
|
Prenatal Care | 1 | 1983 | 1092 | 0.010 |
Why?
|
Hyperpigmentation | 1 | 1997 | 112 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1979 | 2505 | 0.010 |
Why?
|
Clinical Competence | 1 | 1991 | 4687 | 0.010 |
Why?
|
Patient Selection | 1 | 2007 | 4216 | 0.010 |
Why?
|
Recurrence | 1 | 1986 | 8340 | 0.010 |
Why?
|
Employment | 1 | 2001 | 1132 | 0.010 |
Why?
|
Drug Administration Schedule | 3 | 1992 | 4933 | 0.010 |
Why?
|
Marital Therapy | 1 | 1973 | 45 | 0.010 |
Why?
|
Tape Recording | 1 | 1973 | 76 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1995 | 11718 | 0.010 |
Why?
|
Relaxation | 1 | 1973 | 50 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1990 | 4262 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2001 | 1425 | 0.010 |
Why?
|
Radiotherapy Dosage | 3 | 1985 | 2879 | 0.010 |
Why?
|
Education, Medical | 1 | 1985 | 1722 | 0.010 |
Why?
|
Torsion Abnormality | 1 | 1973 | 93 | 0.010 |
Why?
|
Urinary Bladder | 2 | 1991 | 1173 | 0.010 |
Why?
|
Renal Dialysis | 1 | 1982 | 1783 | 0.010 |
Why?
|
Imagination | 1 | 1973 | 221 | 0.010 |
Why?
|
Interviews as Topic | 2 | 1990 | 2539 | 0.010 |
Why?
|
Atrophy | 1 | 1997 | 1584 | 0.010 |
Why?
|
Glioma | 1 | 1987 | 3401 | 0.010 |
Why?
|
Software | 1 | 1986 | 4442 | 0.010 |
Why?
|
Blood Pressure | 1 | 1987 | 8551 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1994 | 1005 | 0.010 |
Why?
|
Genes, Recessive | 1 | 1973 | 641 | 0.010 |
Why?
|
Income | 2 | 1990 | 1913 | 0.010 |
Why?
|
Teaching | 1 | 1977 | 1174 | 0.010 |
Why?
|
Washington | 1 | 1990 | 313 | 0.010 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1988 | 115 | 0.010 |
Why?
|
Family Characteristics | 1 | 1973 | 1000 | 0.010 |
Why?
|
Collagen Diseases | 1 | 1988 | 34 | 0.010 |
Why?
|
Equipment Design | 1 | 1997 | 3582 | 0.010 |
Why?
|
Personality Inventory | 1 | 1991 | 1030 | 0.000 |
Why?
|
Propantheline | 1 | 1987 | 6 | 0.000 |
Why?
|
Dihydroxyphenylalanine | 1 | 1987 | 76 | 0.000 |
Why?
|
Heart Defects, Congenital | 1 | 1984 | 4583 | 0.000 |
Why?
|
Robotics | 1 | 1995 | 899 | 0.000 |
Why?
|
Histological Techniques | 1 | 1987 | 198 | 0.000 |
Why?
|
Pigmentation | 1 | 1987 | 148 | 0.000 |
Why?
|
Algorithms | 1 | 2007 | 13882 | 0.000 |
Why?
|
Pain | 2 | 1997 | 4987 | 0.000 |
Why?
|
Culture Techniques | 1 | 1987 | 554 | 0.000 |
Why?
|
Urination | 1 | 1987 | 204 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1984 | 18034 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1987 | 8862 | 0.000 |
Why?
|
Petrolatum | 1 | 1984 | 8 | 0.000 |
Why?
|
Education | 1 | 1988 | 543 | 0.000 |
Why?
|
Anxiety | 2 | 1991 | 4296 | 0.000 |
Why?
|
Sutures | 1 | 1986 | 299 | 0.000 |
Why?
|
Social Support | 1 | 1994 | 2118 | 0.000 |
Why?
|
Sexual Behavior | 1 | 1973 | 2055 | 0.000 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1983 | 60 | 0.000 |
Why?
|
Whole-Body Irradiation | 1 | 1984 | 449 | 0.000 |
Why?
|
Estriol | 1 | 1983 | 53 | 0.000 |
Why?
|
Buttocks | 1 | 1983 | 110 | 0.000 |
Why?
|
Gels | 1 | 1984 | 427 | 0.000 |
Why?
|
Tyrosine | 1 | 1987 | 1462 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1987 | 2086 | 0.000 |
Why?
|
Educational Status | 1 | 1990 | 2540 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1984 | 1681 | 0.000 |
Why?
|
Outpatients | 1 | 1990 | 1487 | 0.000 |
Why?
|
Astrocytoma | 1 | 1987 | 790 | 0.000 |
Why?
|
Leg | 1 | 1987 | 1116 | 0.000 |
Why?
|
Fetal Heart | 1 | 1983 | 276 | 0.000 |
Why?
|
Mice, Nude | 1 | 1987 | 3689 | 0.000 |
Why?
|
Nausea | 1 | 1982 | 674 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1985 | 2373 | 0.000 |
Why?
|
Transplantation, Heterologous | 1 | 1987 | 2383 | 0.000 |
Why?
|
Collagen | 1 | 1986 | 2688 | 0.000 |
Why?
|
Seasons | 1 | 1982 | 1493 | 0.000 |
Why?
|
Fatigue | 1 | 1982 | 1531 | 0.000 |
Why?
|
Cell Line | 1 | 1987 | 16000 | 0.000 |
Why?
|
Glioblastoma | 1 | 1987 | 3481 | 0.000 |
Why?
|
Ultrasonography | 1 | 1983 | 5984 | 0.000 |
Why?
|